Related Experiment Videos
ERK-1/2 activity is required for efficient RSV infection.
Xiaoyuan Kong1, Homero San Juan, Aruna Behera
1The Joy McCann Culverhouse Airways Disease Research Center, Division of Allergy and Immunology, Department of Internal Medicine, MDC-19, 12901 Bruce B. Downs Blvd, Tampa, FL 33612, USA.
FEBS Letters
|February 13, 2004
Summary
Respiratory syncytial virus (RSV) activates the ERK-1/2 signaling pathway in bronchial cells within minutes of attachment. This pathway is crucial for early gene expression during RSV infection.
Area of Science:
- Virology
- Cellular Biology
- Immunology
Background:
- Respiratory syncytial virus (RSV) infection increases proinflammatory mediators in bronchial epithelial cells.
- The precise early signaling events triggered by RSV exposure remain unclear.
Purpose of the Study:
- To investigate the immediate signaling events following RSV attachment to bronchial epithelial cells.
- To determine the role of specific signaling pathways in early RSV gene expression.
Main Methods:
- Utilized A549 cells as a model for bronchial epithelial cells.
- Monitored the activation of ERK-1 and ERK-2 pathways upon RSV attachment.
- Assessed the impact of ERK pathway inhibition on RSV infection levels.
Main Results:
- RSV attachment rapidly activated both ERK-1 and ERK-2 pathways within 5 minutes.
- Inhibiting the ERK-1/2 pathways significantly reduced RSV infection rates in A549 cells.
- These findings highlight the critical role of ERK-1/2 activation in the early stages of RSV infection.
Conclusions:
- The activation of the ERK-1/2 signaling pathway is an early and essential event following RSV attachment.
- Targeting the ERK-1/2 pathway may represent a potential therapeutic strategy to control RSV infection.